March 18, 2021
Torii Pharmaceutical, a subsidiary of Japan Tobacco, said on March 17 that it has exercised its option to acquire exclusive rights to develop and commercialize Verrica Pharmaceuticals’ skin disease drug candidate VP-102 in Japan. Under their pact, Torii will hold...read more